Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment

Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Despite initial responsiveness, 80% of EOC patients recur and present with chemoresistant and a more aggressive disease. This suggests an underlying biology that results in a modified recurrent disease, which is distinct from...

Full description

Bibliographic Details
Main Authors: Craveiro, Vinicius, Yang-Hartwich, Yang, Holmberg, Jennie C, Sumi, Natalia J, Pizzonia, John, Griffin, Brian, Gill, Sabrina K, Silasi, Dan-Arin, Azodi, Masoud, Rutherford, Thomas, Alvero, Ayesha B, Mor, Gil
Format: Online
Language:English
Published: Blackwell Publishing Ltd 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892380/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892380/

Similar Items